DPP4 and Insulin resistance: Second, patients with type 2 diabetes mellitus in East Asia are characterized by more remarkable β‐cell dysfunction and less insulin resistance than in Caucasians, and DPP4 inhibitors seem to exert better glycemic control in East Asians (26).